Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

ClinicalTrials.gov ID: NCT03132428

Public ClinicalTrials.gov record NCT03132428. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Prospectively Defined Observational Registry With Retrospective Data Collection, Evaluating Premature and Term-Near-Term Neonates With Pulmonary Hypertension Receiving Inhaled Nitric Oxide Via Invasive or Noninvasive Ventilation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Pulmonary hypertension is high blood pressure in the arteries to the lungs. It is a serious condition. It causes the blood vessels that carry blood from the heart to the lungs to become hard and narrow. When this happens, the heart has to work harder to pump the blood through. Some babies are born with pulmonary hypertension (PH). Doctors might use INOmax (a gas the baby breathes) to help newborn babies (neonates) with PH. This study will use information from the records of registered babies to see how effective and safe INOmax is for treating premature and other newborn babies for up to 11 days after they are born.

Study identification

NCT ID
NCT03132428
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Mallinckrodt
Industry
Enrollment
140 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
27 Weeks to 40 Weeks
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 27, 2017 (Actual)
Primary completion
Feb 11, 2020 (Actual)
Completion
Feb 11, 2020 (Actual)
Last update posted
Jun 18, 2020

2017 – 2020

United States locations

U.S. sites
30
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Banner Good Samaritan Medical Center Phoenix Arizona 85006 —
Arkansas Children's Hospital Research Institute Little Rock Arkansas 72202 —
Loma Linda University Health Care Loma Linda California 92354 —
Miller Children's and Women's Hospital - Long Beach Long Beach California 90801 —
Children's Hospital of Orange County Orange California 92868 —
Sharp Mary Birch Hospital for Women and Newborns San Diego California 92123 —
UCSF Benioff Children's Hospital San Francisco California 94143 —
Yale New Haven Children's Hospital New Haven Connecticut 06520 —
Florida Hospital for Children Orlando Florida 32803 —
University of South Florida Tampa Florida 33620 —
University of Chicago Comer Children's Hospital Chicago Illinois 60637 —
University of Iowa Stead Family Children's Hospital Iowa City Iowa 52242 —
University of Kentucky Chandler Lexington Kentucky 40536 —
Norton Children's Hospital Louisville Kentucky 40202 —
University of Minnesota Amplatz Children's Hospital Minneapolis Minnesota 55454 —
University of Mississippi Medical Center Jackson Mississippi 39216 —
Children's Mercy Hospital Kansas City Missouri 64108 —
Saint Louis Children's Hospital St Louis Missouri 63110 —
Children's Hospital of New Jersey at Newark Beth Israel Medical Center Newark New Jersey 07112 —
Duke University Durham North Carolina 27710 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
University Hospitals Rainbow Babies & Children's Hospital Cleveland Ohio 44106 —
Nationwide Children's Hospital Columbus Ohio 43205 —
The Children's Hospital at OU Medical Center Oklahoma City Oklahoma 73104 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15224 —
Women & Infants Hospital of Rhode Island Providence Rhode Island 02905 —
University of Texas Southwestern Medical Center Dallas Texas 75235 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229 —
Virginia Commonwealth University Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03132428, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2020 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03132428 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →